Retinal Vascular Lesions in Patients of Caucasian and Asian Origin With Type 2 Diabetes: Baseline results from the ADVANCE Retinal Measurements (AdRem) study
Stolk et al.
Diabetes Care 2008;31:708-713.
ABSTRACT
| FULL TEXT
Retinal Signs and Stroke: Revisiting the Link Between the Eye and Brain
Baker et al.
Stroke 2008;39:1371-1379.
ABSTRACT
| FULL TEXT
Self-Reported Age-Related Eye Diseases and Visual Impairment in the United States: Results of the 2002 National Health Interview Survey
Ryskulova et al.
Am. J. Public Health 2008;98:454-461.
ABSTRACT
| FULL TEXT
Introduction
Ryan
Am J Health Syst Pharm 2007;64:S2-S2.
FULL TEXT
Etiology and natural history of diabetic retinopathy: An overview
Morello
Am J Health Syst Pharm 2007;64:S3-S7.
ABSTRACT
| FULL TEXT
Association of Statin Use With the Risk of Developing Diabetic Retinopathy
Zhang and McGwin
Arch Ophthalmol 2007;125:1096-1099.
ABSTRACT
| FULL TEXT
Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease
Tuttle et al.
CJASN 2007;2:631-636.
ABSTRACT
| FULL TEXT
Knowledge, Attitudes, and Beliefs about Dilated Eye Examinations among African-Americans
Ellish et al.
IOVS 2007;48:1989-1994.
ABSTRACT
| FULL TEXT
Genome-Wide Linkage Analyses to Identify Loci for Diabetic Retinopathy
Looker et al.
Diabetes 2007;56:1160-1166.
ABSTRACT
| FULL TEXT
Improving Diabetic Retinopathy Screening Ratios Using Telemedicine-Based Digital Retinal Imaging Technology: The Vine Hill Study
Taylor et al.
Diabetes Care 2007;30:574-578.
ABSTRACT
| FULL TEXT
Eye Care in the United States: Do We Deliver to High-Risk People Who Can Benefit Most From It?
Zhang et al.
Arch Ophthalmol 2007;125:411-418.
ABSTRACT
| FULL TEXT
Retinal Dysfunction in Diabetic Ren-2 Rats Is Ameliorated by Treatment with Valsartan but Not Atenolol
Phipps et al.
IOVS 2007;48:927-934.
ABSTRACT
| FULL TEXT
The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy
Ahmed et al.
Diabetes Care 2006;29:2205-2209.
ABSTRACT
| FULL TEXT
The epidemiology of age related eye diseases in Asia.
Wong et al.
Br. J. Ophthalmol. 2006;90:506-511.
ABSTRACT
| FULL TEXT
Serum Inflammatory Markers in Diabetic Retinopathy
Meleth et al.
IOVS 2005;46:4295-4301.
ABSTRACT
| FULL TEXT
Ruboxistaurin, a Protein Kinase C {beta} Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications
Joy et al.
The Annals of Pharmacotherapy 2005;39:1693-1699.
ABSTRACT
| FULL TEXT
Ethnicity, Race, and Baseline Retinopathy Correlates in the Veterans Affairs Diabetes Trial
Emanuele et al.
Diabetes Care 2005;28:1954-1958.
ABSTRACT
| FULL TEXT
Prevalence of Diabetic Retinopathy in Urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I
Rema et al.
IOVS 2005;46:2328-2333.
ABSTRACT
| FULL TEXT
The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C {beta} Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial
The PKC-DRS Study Group
Diabetes 2005;54:2188-2197.
ABSTRACT
| FULL TEXT
Inhibitors of Ocular Neovascularization: Promises and Potential Problems
van Wijngaarden et al.
JAMA 2005;293:1509-1513.
FULL TEXT
The Prevalence of Diabetic Retinopathy Among Adult Type 1 Diabetic Persons in the United States
Roy et al.
Arch Ophthalmol 2004;122:546-551.
ABSTRACT
| FULL TEXT